We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+8.94%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$76.2B
AUM Growth
+$2.6B
(+3.5%)
Cap. Flow
-$2.97B
Cap. Flow
% of AUM
-3.9%
Top 10 Holdings %
Top 10 Hldgs %
21.61%
Holding
3,238
New
235
Increased
684
Reduced
2,065
Closed
243
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$77.3M |
| 2 |
Blackstone
BX
|
+$53.2M |
| 3 |
NXP Semiconductors
NXPI
|
+$40.8M |
| 4 |
Palantir
PLTR
|
+$34.3M |
| 5 |
Snowflake
SNOW
|
+$24.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$206M |
| 2 |
Microsoft
MSFT
|
+$163M |
| 3 |
Linde
LIN
|
+$133M |
| 4 |
Amazon
AMZN
|
+$94.7M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$82.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.34% |
| 2 | Financials | 14.16% |
| 3 | Healthcare | 12.95% |
| 4 | Consumer Discretionary | 12.06% |
| 5 | Communication Services | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ITCI
1726
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $3.02M | ﹤0.01% |
73,866
-20,160
| -21% | -$745K |
|
1727
The GEO Group
GEO
$4.03B
| $3M | ﹤0.01% |
422,066
-20,004
| -5% | -$126K |
|
1728
Artisan Partners
APAM
$3.06B
| $3M | ﹤0.01% |
59,032
-14,971
| -20% | -$787K |
|
1729
Clearway Energy Class C
CWEN
$6.74B
| $3M | ﹤0.01% |
113,128
-4,267
| -4% | -$117K |
|
1730
TriNet
TNET
$3.06B
| $3M | ﹤0.01% |
41,332
-2,716
| -6% | -$211K |
|
|
PRSU
1731
Pursuit Attractions and Hospitality Inc
PRSU
$1.3B
| $2.99M | ﹤0.01% |
60,012
-11,516
| -16% | -$509K |
|
1732
Albertsons Companies
ACI
$5.86B
| $2.98M | ﹤0.01% |
151,850
-1,256
| -0.8% | -$24.4K |
|
|
FOLD
1733
DELISTED
Amicus Therapeutics
FOLD
| $2.98M | ﹤0.01% |
309,263
+2,436
| +0.8% | +$23.8K |
|
|
MFA
1734
MFA Financial
MFA
$915M
| $2.98M | ﹤0.01% |
162,273
-23,732
| -13% | -$419K |
|
1735
Pennant Group
PNTG
$1.36B
| $2.98M | ﹤0.01% |
72,789
-2,870
| -4% | -$112K |
|
1736
Vir Biotechnology
VIR
$1.48B
| $2.98M | ﹤0.01% |
62,951
+2,566
| +4% | +$117K |
|
1737
Hamilton Lane
HLNE
$5.43B
| $2.98M | ﹤0.01% |
32,648
-1,589
| -5% | -$144K |
|
|
DCT
1738
DELISTED
Duck Creek Technologies, Inc. Common Stock
DCT
| $2.97M | ﹤0.01% |
68,261
-541
| -0.8% | -$22K |
|
1739
Andersons Inc
ANDE
$2.31B
| $2.97M | ﹤0.01% |
97,261
-10,195
| -9% | -$307K |
|
1740
Champion Homes
SKY
$4.97B
| $2.96M | ﹤0.01% |
55,545
-3,919
| -7% | -$185K |
|
|
CVGW
1741
DELISTED
Calavo Growers
CVGW
| $2.96M | ﹤0.01% |
46,672
-1,077
| -2% | -$79.1K |
|
|
SAGE
1742
DELISTED
Sage Therapeutics
SAGE
| $2.96M | ﹤0.01% |
52,041
-3,404
| -6% | -$241K |
|
|
DRNA
1743
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $2.95M | ﹤0.01% |
79,063
-4,154
| -5% | -$127K |
|
1744
Goosehead Insurance
GSHD
$2.37B
| $2.95M | ﹤0.01% |
23,150
+2,942
| +15% | +$300K |
|
1745
Designer Brands
DBI
$336M
| $2.95M | ﹤0.01% |
177,996
-39,668
| -18% | -$699K |
|
1746
The Joint Corp
JYNT
$117M
| $2.94M | ﹤0.01% |
35,022
+23,560
| +206% | +$1.46M |
|
1747
Towne Bank
TOWN
$3.44B
| $2.94M | ﹤0.01% |
96,630
-11,505
| -11% | -$361K |
|
1748
Westlake Corp
WLK
$9.9B
| $2.94M | ﹤0.01% |
32,628
-2,954
| -8% | -$287K |
|
1749
Heritage Financial
HFWA
$1.21B
| $2.92M | ﹤0.01% |
116,896
-7,507
| -6% | -$209K |
|
1750
PetMed Express
PETS
$42.1M
| $2.92M | ﹤0.01% |
91,801
-1,357
| -1% | -$43.1K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2021 Portfolio in Review
As of Q2 2021, RhumbLine Advisers held 3,238 positions worth $76.2B, up 3.5% from $73.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
RhumbLine Advisers withdrew a net $2.97B in Q2 2021, closing 243 positions and reducing 2,065 holdings. Its most notable exit was Varian Medical Systems, Inc., an estimated $32.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
Against the trend, RhumbLine Advisers opened a new position in DraftKings worth $14.2M.
- RhumbLine Advisers's largest Q2 2021 buy was DraftKings: 271,227 shares worth $14.2M.
- RhumbLine Advisers added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $77.3M increase.
- RhumbLine Advisers's biggest Q2 2021 reduction was Apple, cutting an estimated $206M.
- RhumbLine Advisers fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $32.1M.
- RhumbLine Advisers's ten largest holdings make up 22% of its $76.2B portfolio in Q2 2021.
- RhumbLine Advisers opened 235 new positions and closed 243 in Q2 2021.
- RhumbLine Advisers's portfolio value rose 3.5% quarter-over-quarter to $76.2B.
Based on RhumbLine Advisers's 13F filing for Q2 2021, filed 5 Aug 2021.